T11778 |
KRas G12C inhibitor 3
|
2206735-75-1
|
98%
|
|
KRas G12C inhibitor 3 is a compound that inhibits KRas G12C.
|
T11769 |
KRAS G12C inhibitor 15
|
2349393-21-9
|
98%
|
|
KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor .
|
T22991 |
ML-099
|
496775-95-2
|
98%
|
|
pan activator of Ras-related GTPases
|
T39738 |
ASP2453
|
2241719-73-1
|
98%
|
|
ASP2453 is a potent, selective and covalent inhibitor of KRAS G12C. ASP2453 inhibits the Son of Sevenless (SOS)-mediated interaction between KRAS G12C and Raf wi...
|
T20759 |
XRP44X
|
729605-21-4
|
98%
|
|
XRP44X is a potent inhibitor of Ras-Net (Elk-3) pathway.
|
T24437 |
MCP110
|
521310-51-0
|
98%
|
|
MCP110 is an inhibitor of the interaction of Ras with Raf-1 and can be used in studies about the treatment of human tumors.
|
T5S1261 |
Methylophiopogonanone B
|
74805-91-7
|
98%
|
|
1. Methylophiopogonanone B (MOPB) induces cell morphological change and Rho activation via melanocyte dendrite retraction and stress fiber formation.
|
T16432 |
Pan-RAS-IN-1
|
1835283-94-7
|
98%
|
|
Pan-RAS-IN-1 is an inhibitor of pan-Ras. It disrupts the interaction of Ras proteins and their effectors.
|
T9407 |
Rasarfin
|
674359-73-0
|
|
|
Rasarfin inhibits Ras and ARF6.
|
T12979 |
BI-3406
|
2230836-55-0
|
100%
|
|
BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity.
|
T3553 |
Y16
|
429653-73-6
|
100%
|
|
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated sign...
|
T8843 |
APS6-45
|
2188236-41-9
|
100%
|
|
APS6-45 inhibits RAS/MAPK signaling and exhibits anti-tumor activity.
|
T9198 |
SCH54292
|
188480-51-5
|
95.65%
|
|
SCH-54292 is a GDP exchange inhibitor.
|
T37422L |
Ras Inhibitory Peptide acetate
|
|
96.63%
|
|
Ras Inhibitory Peptide acetate is a peptide involved in the Ras-dependent signaling pathway that plays an important role in human cancers initiated by oncogenic ...
|
T7414 |
ARS-853
|
1629268-00-3
|
96.64%
|
|
ARS-853 is an inhibitor of K-RASG12C(IC50 : 2.5 μM), a mutant form of K-RAS that accumulates in the active GTP-bound state in certain cancer cells
|
T5418 |
BAY-293
|
2244904-70-7
|
96.8%
|
|
BAY-293 is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction (IC50: 21 nM).
|
T8375 |
ML-210
|
1360705-96-9
|
97%
|
|
ML-210 is a selective RAS and covalent glutathione peroxidase 4 (GPX4) inhibitor(GPX4, EC50 : 30 nM), with anti-cancer activity
|
T2427 |
EHop-016
|
1380432-32-5
|
97.69%
|
|
EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1 in MDA-MB-231 and MDA-MB-435 cells, equally effective inhibition for Rac3.
|
T10376 |
ARS-1630
|
1698055-86-5
|
97.81%
|
|
ARS-1630 is a mutant K-ras G12C inhibitor extracted from patent WO 2015054572 A1. It is a less active enantiomer of ARS-1620.
|
T22249 |
1588-A4
|
1698027-20-1
|
98%
|
|
1588-A4 is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.
|